Synlogic Inc. - SYBX Company Short-Term Debt

Public company logo of Synlogic Corp (SYBX)

Synlogic, Inc. previously implemented automated systems for precision dosing in laboratories. The short-term debt trend demonstrates the current financial burden, where the value of 0.00 describes the current level. Looking ahead, the company plans to monetize bioengineering patents through partnerships with industry behemoths, while simultaneously transitioning to eco-friendly synthesis methods and safe bio-waste disposal to comply with ESG standards.

SYBX (synlogictx.com) Company Short-Term Debts history from 07/04/2022 to 01/24/2026

Summary analytical data breakdowns for Synlogic Inc. (SYBX)

- price and consensus price forecast:
Price Chart Synlogic Corp|SYBX - Fair Value Consensus
- market capitalization data:
Market Value Synlogic, Inc.|SYBX - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Synlogic|SYBX - Book Capitalization|Market Cap to Net Assets Ratio synlogictx.com|SYBX - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Synlogic, Inc.|SYBX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Synlogic Corp|SYBX - Company Cumulative Debt|Debt to Book Value Synlogic, Inc.|SYBX - Amount of Long-Term Liabilities|Company Short-Term Debts Synlogic
Initial company analysis:SYBX (synlogictx.com)
Flagship merchandise of Synlogic Inc.

Short-term debts measure the volume of urgent obligations that require a constant inflow of liquidity to prevent cash gaps and ensure solvency. An analysis of changes in short-term liabilities on GURU.Markets allows for an assessment of the financial stability of Synlogic, Inc. (SYBX), where the transition to intellectual property licensing and digital microbe modeling minimizes capital expenditures, reducing reliance on external borrowings.

Competitors of Synlogic, Inc. (SYBX)

Company Short-Term Debt Ascendis Pharma (ASND)|MDGL: Company Short-Term Loans and Borrowings|CORT (Corcept) - Company Short-Term Debt|Rhythm Corp (RYTM) - Company Current Liabilities|AKRO (Akero Therapeutics) - Company Short-Term Debts|Company Short-Term Debts metsera.com (MTSR)|MoonLake (MLTX) - Company Current Liabilities|Company Short-Term Loans and Borrowings CRNX (Crinetics Pharmaceuticals, Inc.)|NewAmsterdam Pharma N.V. - Company Short-Term Debt|Company Current Liabilities Soleno Therapeutics Corp SLNO|FOLD (Amicus Therapeutics) - Company Short-Term Debts|89bio.com (ETNB) - Short-Term Debt|AGIO - Company Current Liabilities|Structure Therapeutics Inc (GPCR) - Amount of Current Liabilities|MDXG (MiMedx Group) - Company Short-Term Debts|Company Short-Term Debts Rezolute Bio|Company Short-Term Debts Lexicon Pharmaceuticals (LXRX)|Company Short-Term Debt MBX (mbxbio.com)|ALT: Company Short-Term Debt|Aardvark Therapeutics Inc. - Short-Term Debt|SGMT - Company Short-Term Debt|BIOA - Company Short-Term Debt|Biomea Fusion, Inc. - Company Short-Term Debts|QNCX (Quince Therapeutics, Inc.) - Short-Term Debt Volume|GUTS: Company Short-Term Debt|Short-Term Debt Volume VTVT|Company Short-Term Debt ATPC (Agape ATP Corporation)|Company Current Liabilities PLUR (pluri-biotech.com)|Company Short-Term Debt LPCN|MTNB - Short-Term Debt Volume|SPRB (Spruce Biosciences) - Company Current Liabilities|GLTO: Short-Term Debt|Company Short-Term Debt Carmell Corp|LUMO (Lumos Therapeutics) - Company Short-Term Indebtedness|Company Short-Term Debt Organovo Holdings, Inc.|Company Short-Term Debt RDUS